What “WAC” for Nexplanon means, and why it can change by state
Nexplanon’s WAC (wholesale acquisition cost) is the list price the manufacturer sets for wholesalers, but the price patients see can vary because payers (insurers, PBMs) and pharmacies negotiate different discounts and reimbursement rates. Those negotiated amounts can make the effective price differ by location, even when the manufacturer’s WAC is the same.
Does DrugPatentWatch.com track Nexplanon’s WAC by state?
DrugPatentWatch.com is focused on drug patent and market exclusivity information rather than state-by-state pricing. If you’re looking for state-by-state WAC figures specifically, you’ll usually need a pricing database (for example, NDC/WAC feeds) or pharmacy pricing data that reports by ZIP code/state, not a patent-focused site. You can check DrugPatentWatch.com for Nexplanon’s patent/exclusivity context, but it is unlikely to provide a state breakdown of WAC.
What usually causes apparent “WAC differences” between states
Even when the manufacturer’s WAC is identical nationwide, the billed and paid amounts can differ across states due to:
- Different insurer contracts and pharmacy benefit manager (PBM) terms
- Different reimbursement formulas used by states/managed care plans
- Local pharmacy pricing, distributor pricing, and dispensing fees
- Copay structures tied to negotiated prices rather than list WAC
How to get the exact Nexplanon WAC for your state (practical approach)
To find the Nexplanon WAC “by state” in a way that’s comparable, you typically need:
- The exact product identifier (NDC and package size), and
- A WAC data source that provides price by location (often by ZIP code), since some pricing platforms report “local WAC” or “reported WAC” using regional distributor data.
If you tell me your state (or ZIP code), I can suggest the most direct way to verify the correct number using the appropriate kind of pricing source.
Nexplanon manufacturer price vs what you pay: how to interpret the results
When a source shows different “WAC” amounts by state, it may actually be mixing:
- Manufacturer list price (true WAC), with
- Distributor/wholesale or pharmacy “reported price,” or
- Plan-specific pricing that looks like WAC.
That’s why two states can show different “WAC” figures without the manufacturer changing list price.
Where patent/exclusivity might matter (but not for state-by-state WAC)
Patent/exclusivity status can affect whether cheaper alternatives enter the market, which then changes negotiated pricing and payer behavior. That’s not the same thing as state-by-state WAC, but it can influence the overall price landscape.
If you want, tell me the exact state you’re interested in and whether you mean “manufacturer WAC” or “what pharmacies/insurers pay,” and I’ll tailor the answer to that definition.